Citation Impact
Citing Papers
Atorvastatin and fluvastatin are associated with dose‐dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
2016
HER2 and Response to Paclitaxel in Node-Positive Breast Cancer
2007
Low-molecular-weight cyclin E: the missing link between biology and clinical outcome
2004
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Triple-Negative Breast Cancer
2010 Standout
Microtubule Dynamics during the Cell Cycle: The Effects of Taxol and Nocodazole on the Microtubule System of Pt K2 Cells at Different Stages of the Mitotic Cycle
1986
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Cyclin E as a prognostic and predictive marker in breast cancer
2005
Bioluminescent imaging of Cdk2 inhibition in vivo
2004 StandoutNobel
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Hepatocellular carcinoma
2018 Standout
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium
2013
Proteasome inhibitors: from research tools to drug candidates
2001
Lovastatin and simvastatin are modulators of the proteasome
2000 StandoutNobel
Racial differences in the expression of cell cycle–regulatory proteins in breast carcinoma
2004
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
2001
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Cyclin E in normal and neoplastic cell cycles
2005
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
2006 StandoutNature
Paclitaxel (Taxol)
1995 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Staufen protein associates with the 3′UTR of bicoid mRNA to form particles that move in a microtubule-dependent manner
1994 StandoutNobel
Regulation of apoptosis by the ubiquitin and proteasome pathway
2002
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
The Tumor-specific Hyperactive Forms of Cyclin E Are Resistant to Inhibition by p21 and p27
2005
A Highly Conserved Signal Controls Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) Reductase in Eukaryotes
1999
Statins and Prostate Cancer Risk: A Case-Control Study
2005
p27 Kip1 and Cyclin E Expression and Breast Cancer Survival After Treatment With Adjuvant Chemotherapy
2006
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
The Cyclin-Ubiquitin Ligase Activity of Cyclosome/APC Is Jointly Activated by Protein Kinases Cdk1-Cyclin B and Plk
2002 StandoutNobel
Protein degradation and protection against misfolded or damaged proteins
2003 StandoutNature
Cyclin E Expression and Prognosis in Breast Cancer Patients: A Meta-Analysis of Published Studies
2006
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
2005
Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
2008 StandoutNobel
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.
1994
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma1
2006
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Cyclin-dependent kinases as new targets for the prevention and treatment of cancer
2002
Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity
2001
Paclitaxel and its formulations
2002 Standout
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Chapter 11 Proteinase families and their inhibitors
2001
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Preservation of Fertility in Patients with Cancer
2009 Standout
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
2012
Hepatocellular carcinoma
2022 Standout
Emerging targeted agents in metastatic breast cancer
2013
Cancer of the Ovary
2004 Standout
ExCage
2014 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Cyclin E Both Regulates and Is Regulated by Calpain 2, a Protease Associated with Metastatic Breast Cancer Phenotype
2005
Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data
1991
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms
1989
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer
2004
A Familial Visceral Myopathy
1978
Taxol: A New Probe for Studying the Structure and Function of Microtubules
1982
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
Anaphase-Promoting Complex/Cyclosome–Dependent Proteolysis of Human Cyclin a Starts at the Beginning of Mitosis and Is Not Subject to the Spindle Assembly Checkpoint
2001 StandoutNobel
Band Bending in Semiconductors: Chemical and Physical Consequences at Surfaces and Interfaces
2012 Standout
Near-field photoconductivity: Application to carrier transport in InGaAsP quantum well lasers
1994 StandoutNobel
Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms
2001
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
2001
Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients
2006
Crystal Growth of Extended Solids by Nonaqueous Gel Diffusion
1997 StandoutNobel
High-Risk Breast Lesions: A Machine Learning Model to Predict Pathologic Upgrade and Reduce Unnecessary Surgical Excision
2017
Naphthalene: A Respiratory Tract Toxicant and Carcinogen for Mice
1992
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Minority Carrier Transport in Lead Sulfide Quantum Dot Photovoltaics
2017 StandoutNobel
Emerging Targets in Photopharmacology
2016 StandoutNobel
Neural Computing in Cancer Drug Development: Predicting Mechanism of Action
1992 StandoutScienceNobel
Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer
2003
Charge collection scanning electron microscopy
1982
Mitotic Regulation of the APC Activator Proteins CDC20 and CDH1
2000
The dissociation of nuclear and centrosomal division in gnu, a mutation causing giant nuclei in Drosophila
1986 StandoutNobel
Scanning Electron Microscopy of Intracellular Structures
1980
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Tomographic three-dimensional reconstruction of cilia ultrastructure from thick sections.
1986 StandoutNobel
TBX3 Is Overexpressed in Breast Cancer and Represses p14ARF by Interacting with Histone Deacetylases
2008
Scanning electron microscopy
1982
Works of Michael Lowe being referenced
UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent
1999
Cyclin E and Survival in Patients with Breast Cancer
2002
Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53
1998
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
2001
Management of Papillary Breast Lesions Diagnosed on Core-Needle Biopsy: Clinical Pathologic and Radiologic Analysis of 276 Cases with Surgical Follow-Up
2012
Clara cell damage and inhibition of pulmonary mixed-function oxidase activity by naphthalene
1981
Effects of organic acids on tubulin polymerization and associated GTP hydrolysis
1982
Scanning Electron Microscopy/1975
1976
Studies of Idiopathic Intestinal Pseudoobstruction
1977
Lovastatin-mediated G 1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase
1999
Interactions of taxol, microtubule-associated proteins, and guanine nucleotides in tubulin polymerization.
1981